SOUTHERN RESEARCH INSTITUTE

Funding Organization

Awards Grant

  • Antisense Oligonucleotide Knockdown of the Transcriptional Repressor RIP140 to Enhance Survival of Dopaminergic Neurons in a Mouse of PD
  • Cellular Mechanism of Synchrony Impairments in Schizophrenia
  • Development of a Drug Eluting Band/Glove for Treatment of Osteoarthritis
  • Glial Involvement in REDOX Homeostasis in the Substantia Nigra
  • HTS Assay for Identification of Small Molecule Inhibitors of Venezuelan Equine Encephalitis
  • High-Throughput Screen for Small Compounds that Reactivate Fetal Hemoglobin in Adults Cells Synthesizing Sickle Hemoglobin
  • Interrogation of Key Genomic Alterations in Glioblastoma Multiforme (GBM) for Identification of Molecular Pathways Critical to GBM Tumorigenesis and Progression
  • Interrogation of Key Genomic Alterations in Glioblastoma Multiforme (GBM) for Identification of Molecular Pathways Critical to GBM Tumorigenesis and Progression
  • Investigating Vulnerability of Recently Identified Subsets of Dopaminergic Neurons in the Rodent and Human Substantia Nigra
  • Non-Contact Vitals Monitoring for Potential COVID-19 Positive Patients
  • Task 3.2 Oxygen Consumption Rate (OCR) and Extracellular Acidification
  • Testing the Neuroprotective Efficacy of Atp6v0a1 Modulation
  • The Identification of New Treatments for Cystic Fibrosis Caused by Premature Termination Codons
  • The Identification of New Treatments for Cystic Fibrosis Caused by Premature Termination Codons-Bedwell Subcontract
  • Transcriptional Regulation of Metabolism in Neurons
  • UAB 19113: A Phase 1 Study of NTX-301, an Oral DNMT1 Inhibitor, in Patients with MDS and AML